FI921598A0 - Transdermal komposition. - Google Patents
Transdermal komposition.Info
- Publication number
- FI921598A0 FI921598A0 FI921598A FI921598A FI921598A0 FI 921598 A0 FI921598 A0 FI 921598A0 FI 921598 A FI921598 A FI 921598A FI 921598 A FI921598 A FI 921598A FI 921598 A0 FI921598 A0 FI 921598A0
- Authority
- FI
- Finland
- Prior art keywords
- transdermal composition
- transdermal
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919108358A GB9108358D0 (en) | 1991-04-18 | 1991-04-18 | Heterocyclic compounds |
GB919108357A GB9108357D0 (en) | 1991-04-18 | 1991-04-18 | Heterocyclic amides |
GB929205392A GB9205392D0 (en) | 1992-03-12 | 1992-03-12 | Heterocyclic amides |
Publications (2)
Publication Number | Publication Date |
---|---|
FI921598A0 true FI921598A0 (fi) | 1992-04-10 |
FI921598A FI921598A (fi) | 1992-10-19 |
Family
ID=27265602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI921598A FI921598A (fi) | 1991-04-18 | 1992-04-10 | Transdermal komposition |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0509769B1 (fi) |
JP (1) | JPH0656785A (fi) |
KR (1) | KR920019750A (fi) |
AU (1) | AU660664B2 (fi) |
CA (1) | CA2065794A1 (fi) |
CS (1) | CS117692A3 (fi) |
DE (1) | DE69213537T2 (fi) |
FI (1) | FI921598A (fi) |
GB (1) | GB9207145D0 (fi) |
HU (1) | HUT66541A (fi) |
IE (1) | IE921159A1 (fi) |
IL (1) | IL101555A0 (fi) |
NO (1) | NO921451L (fi) |
NZ (1) | NZ242322A (fi) |
TW (1) | TW262475B (fi) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521179A (en) * | 1991-04-18 | 1996-05-28 | Zeneca Limited | Heterocyclic amides |
GB9307555D0 (en) * | 1992-04-16 | 1993-06-02 | Zeneca Ltd | Heterocyclic compounds |
CA2133657A1 (en) * | 1992-04-16 | 1993-10-28 | Peter R. Bernstein | Substituted derivatives |
US5486529A (en) * | 1992-04-16 | 1996-01-23 | Zeneca Limited | Certain pyridyl ketones for treating diseases involving leukocyte elastase |
US5441960A (en) * | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
JPH07505875A (ja) * | 1992-04-16 | 1995-06-29 | ゼネカ・リミテッド | α−アミノボロン酸ペプチドおよびエラスターゼ阻害物質としてのそれらの用途 |
GB9211783D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Amide derivatives |
GB9214053D0 (en) * | 1992-07-02 | 1992-08-12 | Ici Plc | Heterocyclic amides |
US5656645A (en) * | 1994-12-13 | 1997-08-12 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
US6608204B1 (en) * | 1994-12-13 | 2003-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
US5658930A (en) * | 1994-12-13 | 1997-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
CA2219364A1 (en) * | 1995-04-27 | 1996-10-31 | Hideki Okunishi | Heterocyclic amide compounds and pharmaceutical use thereof |
CA2224437A1 (en) * | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
US5668289A (en) * | 1996-06-24 | 1997-09-16 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
US5872138A (en) * | 1996-09-13 | 1999-02-16 | Merck & Co., Inc. | Thrombin inhibitors |
US5869487A (en) * | 1996-10-24 | 1999-02-09 | Merck & Co., Inc. | Pyrido 3,4-B!pyrazines for use as thrombin inhibitors |
WO1998018794A1 (fr) * | 1996-10-25 | 1998-05-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales |
US6017934A (en) * | 1997-01-22 | 2000-01-25 | Merck & Co., Inc. | Thrombin inhibitors |
US5792779A (en) * | 1997-02-19 | 1998-08-11 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
US6087373A (en) * | 1997-09-23 | 2000-07-11 | Merck & Co., Inc. | Thrombin inhibitors |
US6133297A (en) * | 1997-09-30 | 2000-10-17 | Merck & Co., Inc. | Thrombin inhibitors |
EP1062949A4 (en) * | 1998-03-11 | 2002-10-09 | Mitsubishi Pharma Corp | INHIBITORS OF IgE ANTIBODY PRODUCTION AND INHIBITORS OF AUTOIMUN DISEASES |
US6147078A (en) * | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
EP1117660A4 (en) * | 1998-09-28 | 2002-01-09 | Merck & Co Inc | THROMBIN INHIBITORS |
US6610692B1 (en) | 1998-10-30 | 2003-08-26 | Merck & Co., Inc. | Thrombin inhibitors |
WO2000026210A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
US6239132B1 (en) | 1999-04-23 | 2001-05-29 | Merck & Co., Inc. | Thrombin inhibitors |
UA58636C2 (uk) | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
CA2374654A1 (en) | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Thrombin inhibitors |
CA2391012A1 (en) | 1999-11-23 | 2001-05-31 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
AU2001245856A1 (en) | 2000-03-23 | 2001-10-03 | Merck & Co., Inc. | Thrombin inhibitors |
TW200500341A (en) * | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
PE20050159A1 (es) * | 2003-05-27 | 2005-04-19 | Vertex Pharma | Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa |
SE0302487D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
AU2005309776B2 (en) | 2004-11-24 | 2011-12-22 | Vertex Pharmaceuticals Incorporated | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
BRPI0611348A2 (pt) | 2005-06-07 | 2010-12-07 | Pharmacopeia Inc | composto, formulação farmacêutica, método para realizar diurese ou tratamento de um distúrbio, e, uso de um composto |
KR20080022092A (ko) * | 2005-06-08 | 2008-03-10 | 노파르티스 아게 | 유기 화합물 |
CN110950807B (zh) * | 2018-09-26 | 2023-03-03 | 中国科学院上海药物研究所 | 联芳基类化合物、其制备方法、药物组合物及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474778A (en) * | 1983-11-09 | 1984-10-02 | E. R. Squibb & Sons, Inc. | Lactam containing compounds, their pharmaceutical compositions and method of use |
GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
-
1992
- 1992-04-01 GB GB929207145A patent/GB9207145D0/en active Pending
- 1992-04-10 CA CA002065794A patent/CA2065794A1/en not_active Abandoned
- 1992-04-10 IL IL101555A patent/IL101555A0/xx unknown
- 1992-04-10 FI FI921598A patent/FI921598A/fi not_active Application Discontinuation
- 1992-04-10 HU HU9201225A patent/HUT66541A/hu unknown
- 1992-04-10 IE IE115992A patent/IE921159A1/en unknown
- 1992-04-10 NZ NZ242322A patent/NZ242322A/en unknown
- 1992-04-10 KR KR1019920006072A patent/KR920019750A/ko not_active Application Discontinuation
- 1992-04-10 AU AU14827/92A patent/AU660664B2/en not_active Ceased
- 1992-04-10 NO NO92921451A patent/NO921451L/no unknown
- 1992-04-15 EP EP92303358A patent/EP0509769B1/en not_active Expired - Lifetime
- 1992-04-15 DE DE69213537T patent/DE69213537T2/de not_active Expired - Fee Related
- 1992-04-16 CS CS921176A patent/CS117692A3/cs unknown
- 1992-04-18 JP JP4143140A patent/JPH0656785A/ja active Pending
- 1992-04-29 TW TW081103383A patent/TW262475B/zh active
Also Published As
Publication number | Publication date |
---|---|
NO921451L (no) | 1992-10-19 |
TW262475B (en) | 1995-11-11 |
NO921451D0 (no) | 1992-04-10 |
GB9207145D0 (en) | 1992-05-13 |
EP0509769B1 (en) | 1996-09-11 |
EP0509769A2 (en) | 1992-10-21 |
AU660664B2 (en) | 1995-07-06 |
AU1482792A (en) | 1992-10-22 |
DE69213537D1 (de) | 1996-10-17 |
IL101555A0 (en) | 1992-12-30 |
IE921159A1 (en) | 1992-10-21 |
EP0509769A3 (en) | 1993-09-01 |
NZ242322A (en) | 1994-12-22 |
HU9201225D0 (en) | 1992-07-28 |
KR920019750A (ko) | 1992-11-19 |
JPH0656785A (ja) | 1994-03-01 |
HUT66541A (en) | 1994-12-28 |
CA2065794A1 (en) | 1992-10-19 |
FI921598A (fi) | 1992-10-19 |
DE69213537T2 (de) | 1997-02-20 |
CS117692A3 (en) | 1992-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI921598A0 (fi) | Transdermal komposition. | |
DE69205133D1 (de) | Klebstoffzusammensetzung. | |
DE68907659D1 (de) | Warmhaertende organosiloxanzusammensetzung. | |
FI910310A0 (fi) | Acesulfam-k-innehaollande komposition. | |
DE68916395T2 (de) | Zusammensetzung. | |
DE68906193T2 (de) | Hypersphyxia verursachende zusammensetzung. | |
FI914735A0 (fi) | Med ledbommar foersedd arbetsmaskin. | |
DE68903729D1 (de) | Tertiaere thiolaethoxylat-zusammensetzung. | |
FI912080A0 (fi) | Lagringslaoda foersedd med en gavelvaeggen slutande genomsynlig klaffskiva. | |
DE69225266T2 (de) | Bis-bibenzimidazol Zusammensetzung | |
BR9202742A (pt) | Composicao delimpeza | |
FI892552A0 (fi) | Benzoyl- och ketonperoxidkomposition. | |
FI925175A0 (fi) | Kompositioner haerdbara medelst straolning | |
NO924484D0 (no) | Pesticid sammensetning | |
FI920215A (fi) | Isolering med mycket laog stelningspunkt. | |
DE69206398T2 (de) | Reichstoffzusammensetzungen. | |
FI922185A0 (fi) | Faergframkallande komposition. | |
DE68916142T2 (de) | Zusammensetzung. | |
DE68909455D1 (de) | Polyaethylen-zusammensetzung. | |
FI923996A0 (fi) | Komposition av naturliga antioxidanter foer stabilisering av fleromaettade oljor. | |
ATE88637T1 (de) | Hypersphyxia verursachende zusammensetzung. | |
FI916035A0 (fi) | Ny farmaceutisk komposition. | |
FI914571A0 (fi) | Surgoerande komposition innehaollande diatomacejord. | |
OA09224A (fr) | Composition ADT1 - ANTI - DIABETIQUE. | |
MX9206975A (es) | Composicion farmaceutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |